Catalogue illustration · 7.5 mg
Research material
Sermorelin
Growth-hormone secretagogues
3 mL pen · 7.5 mg
GRF(1-29), the shortest fully active fragment of growth-hormone-releasing hormone.
Supplied for laboratory research use only. Not for human or animal consumption. Price is per pen, EU delivery included.
- Total fill
- 7.5 mg
- Format
- 3 mL pen
- Material
- Research material
- Purpose
- Laboratory research
01 — The format
The catalogue format.
Sermorelin is listed as 7.5 mg in a 3 mL pre-filled pen. The listed quantity is total content per pen, not an administration dose.
The catalogue format does not establish concentration accuracy, stability or delivered volume. These require product-specific documentation.
No reconstitution, dosing or application instructions are supplied. Request the material specification and lot documentation for your laboratory review.
02 — The sequence
The sequence and its identity.
GRF(1-29), the shortest fully active fragment of growth-hormone-releasing hormone.
Reference sequence: Not available — a verified sequence for the supplied material has not been published.
Historical medicine approval: Geref was discontinued. FDA determined that it was not withdrawn from sale for safety or effectiveness reasons. This is not current approval of an Aevamere product.
Reference sources: FDA: Geref discontinuation determination
Reference, not verification. Reference descriptions concern the named compound. They do not verify the contents, purity, biological activity or safety of a supplied batch.
03 — Specification
Analytical data and documentation.
- Compound
- Sermorelin
- Catalogue fill
- 7.5 mg
- Format
- 3 mL pre-filled pen, as listed in the catalogue
- Reference sequence
- Not available — a verified sequence for the supplied material has not been published.
- Molecular formula / mass
- Not verified for the supplied form — request the product specification.
- Salt / counterion
- Not published for this product.
- Batch / lot
- Not available on this page.
- Measured purity
- Not available — no product-matched analytical report has been provided.
- Identity result
- Not available — reference identity is not a measured batch result.
- Endotoxin / sterility
- Not available — no product-matched results have been provided.
- Storage / expiry
- Consult the product-specific label and supporting stability documentation; not verified here.
04 — Batch documentation
Batch results not published.
No verified, product-matched batch report is available on this page. Purity, identity, endotoxin and sterility results are not inferred from the compound name or another product.
Chromatography and mass spectrometry are examples of analytical approaches. The appropriate methods depend on the material; naming a method is not evidence that testing was performed.
Request the specific lot and its supporting reports
Request documentation05 — Handling
Supplied as laboratory research material.
Sermorelin is sold for in-vitro and analytical research use. This page does not establish marketing authorisation and gives no usage, dosing or application guidance of any kind.
- For in-vitro and analytical laboratory research use only
- Not for human or animal consumption
- Not for clinical, diagnostic, therapeutic or cosmetic use
- Follow product-specific documentation and your laboratory procedures
- No dosing or administration guidance is provided
06 — What arrives
In the box.
- Catalogue format: one 3 mL pen · 7.5 mg.
- Confirm packaging, accessories and documentation with the supplier before ordering.
- Batch certificates, storage records and expiry documentation have not been published on this page.
07 — Questions
About this sequence specifically.
- What quantity does this page describe?
- 7.5 mg per 3 mL pen. This is a catalogue quantity, not dosing guidance.
- Is the sequence a batch test?
- Not available — a verified sequence for the supplied material has not been published.
- Where are the analytical results?
- No product-matched certificate is published here. Request the lot number, methods, results and acceptance criteria before evaluating the material.
- Does a medicine approval apply to this pen?
- Historical medicine approval: Geref was discontinued. FDA determined that it was not withdrawn from sale for safety or effectiveness reasons. This is not current approval of an Aevamere product.
The rest of the collection
Held to the same standard.
Accounts & bulk supply
Ask about this material.
For availability, product specifications, batch documentation or bulk quantities, tell us what your laboratory requires.